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Abstract
Background: Dual epidemics of the malaria parasite Plasmodium and HIV-1 in sub-Saharan Africa and Asia present a
significant risk for co-infection in these overlapping endemic regions. Recent studies of HIV/Plasmodium falciparum co-
infection have reported significant interactions of these pathogens, including more rapid CD4+ T cell loss, increased viral
load, increased immunosuppression, and increased episodes of clinical malaria. Here, we describe a novel rhesus macaque
model for co-infection that supports and expands upon findings in human co-infection studies and can be used to identify
interactions between these two pathogens.
Methodology/Principal Findings: Five rhesus macaques were infected with P. cynomolgi and, following three parasite
relapses, with SIV. Compared to macaques infected with SIV alone, co-infected animals had, as a group, decreased survival
time and more rapid declines in markers for SIV progression, including peripheral CD4+ T cells and CD4+/CD8+ T cell ratios.
The naı ¨ve CD4+ T cell pool of the co-infected animals was depleted more rapidly than animals infected with SIV alone. The
co-infected animals also failed to generate proliferative responses to parasitemia by CD4+ and CD8+ T cells as well as B cells
while also having a less robust anti-parasite and altered anti-SIV antibody response.
Conclusions/Significance: These data suggest that infection with both SIV and Plasmodium enhances SIV-induced disease
progression and impairs the anti-Plasmodium immune response. These data support findings in HIV/Plasmodium co-
infection studies. This animal model can be used to further define impacts of lentivirus and Plasmodium co-infection and
guide public health and therapeutic interventions.
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Introduction
Humanimmunodeficiencyvirustype1 (HIV)andPlasmodium,the
malaria parasite, each present immense disease burdens worldwide.
Over 33 million people are infected with HIV resulting in 3 million
deaths annually [1], and each year there are approximately 500
million episodes of clinical malaria leading to over 1 million deaths
[2]. With large overlapping endemic regions and the large numbers
of people infected, especially in Sub-Saharan Africa and Southeast
Asia, there is high risk of co-infection with HIV and Plasmodium.
Recent studies on P. falciparum and HIV co-infection have found
significant interactions between these two pathogens. HIV infection
appears to increase the risk of both malaria parasite infection and
the development of clinical malaria [3–10], and this risk rises with
HIV-induced immunosuppression [4,6–9]. P. falciparum infection
also appears to have an impact on the HIV infection through a
transient increase inHIV viralload [11,12] and a more rapid CD4+
T cell decline [13]. A recent report by Abu-Raddad and colleagues
described dual HIV/Plasmodium infection in Kisumu, Kenya (pop
200,000) enhanced the spread of both pathogens, leading to an
increase of, from 1980 to 2005, approximately one million episodes
of clinical malaria and 8,500 cases of HIV infection [10]. Clearly,
co-infection has an immense impact on both diseases’ progression
and on the associated public health response. A well-defined animal
model could help guide such a response as well as help gain insight
on the pathogenesis of both infections.
PLoS ONE | www.plosone.org 1 September 2009 | Volume 4 | Issue 9 | e7139Simian immunodeficiency virus (SIV) infection in rhesus
macaques has been widely used to model events during HIV
infection [14–18]. During the acute HIV/SIV infection, there is a
rapid and nearly complete depletion of the mucosal CD4+ T cell
population [17] followed by a gradual decline in the peripheral
CD4+ T cell population [16]. An attempt is made to replenish the
lost memory CD4+ T cell pool by the naı ¨ve T cell population
among conventional progressors, leading to a depletion of the
naı ¨ve T cell pool and, ultimately, immune system collapse and
disease [15]. P. vivax, a relapsing malaria parasite, causes disease
during its clinically relevant blood stage through the development
of a strong pro-inflammatory immune response and erythrocyte
loss. Clinical immunity, which develops following multiple parasite
exposures, has been associated with a cell-mediated response
against the parasite’s liver stage [19] and a required humoral
response against the parasite’s blood stage [20].
Currently there are no animal models for investigating the
immunological impact of co-infection. Such a model would allow
for control of confounding variables, such as multiple other
infections, nutritional status, and ethical concerns, which could
impact such studies in humans. To address the immunological
impact of co-infection, we developed an Indian rhesus macaque
co-infection model for HIV-1 and the relapsing malaria parasite P.
vivax using SIV/Delta/B670 and P. cynomolgi, both established
infection models for HIV [14,18] and P. vivax [21] infections in
rhesus macaques.
Results
The pattern of co-infection we have chosen to model is adults
living in regions of the world, such as Southeast Asia, that have a
high incidence of new HIV-1 infections and are endemic for P.
vivax malaria. Most individuals co-infected with HIV-1 and
malarial parasites in these regions were exposed to Plasmodium
before infection with HIV-1 as adults. To more closely model
natural human exposure, co-infected animals were first inoculated
with P. cynomolgi and then with SIV following the third parasite
relapse for a total of four parasitemias (Figure 1). All parasite-
infected animals were treated with chloroquine following parasite
blood-stage emergence, which is necessary to avoid uncontrolled
progression of the parasite infection and to avoid preventable
distress or death of the animals. This treatment plan also more
accurately models human malaria treatment in HIV positive
individuals. All animals were closely monitored, and SIV-infected
animals were humanely sacrificed following progression to
Acquired Immune Deficiency Syndrome (AIDS).
Animals infected with P. cynomolgi in both the singly infected and
co-infected groups displayed the expected malaria disease course
with relapses occurring approximately once a month. Due to
logistical reasons, the malaria-only group was inoculated at a later
date than the SIV-infected animals. As a result the co-infected
animals received a somewhat greater number of sporozoites due to
decreased sporozoite yield when preparing the inoculums for the
malaria-only animals. Since the number of parasite relapses is
directly related to the number of sporozoites inoculated [22], the
malaria-only animals did have fewer relapses than the co-infected
animals. Additionally, the co-infected animals continued to relapse
throughout the entire course of the SIV infection. While the
difference in sporozoite number might have an impact during the
erythrocytic stage, the chloroquine treatment following parasite
appearance in the blood should have minimized such an effect by
limiting parasitemias among the animals.
Figure 1. Experimental protocol. Eighteen rhesus macaques were randomly divided among three groups: SIV/malaria, SIV-only, and malaria-only.
There were five experimental animals and one uninfected control animal (*) in each group. On day 0 the malaria parasite infected animals were
inoculated with Plasmodium cynomolgi, and the SIV infected animals were inoculated with SIV/Delta/B670 following the third parasite relapse (day 86).
doi:10.1371/journal.pone.0007139.g001
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animals
There is much evidence from HIV/P. falciparum co-infection
studies suggesting a negative outcome in co-infected individuals.
From the present study, co-infection appears to increase the risk of
SIV disease progression. All animals in the co-infected group
progressed to AIDS while three out of five of the SIV-only animals
progressed to AIDS during the three-year period of observation
(Kaplan-Meier survival curve, Figure 2A). While the median
animal of each group died at about the same time, the co-infected
group survived a combined 1657 days while the SIV-only group
survived a combined 2657 days with two animals in the SIV-only
group surviving to the end of the study without progressing to
AIDS. Predicting disease progression in SIV-infected macaques is
not possible currently. However, it is possible that the Plasmodium
co-infection could have converted conventional SIV progressors
into more rapid progressors.
The co-infected group had a somewhat lower viral set point
when compared with the SIV-only group (2.57610
6 vs. 9.95610
6
at day 114, respectively; Figure 2B and C) with each group having
a rapid progressor that failed to control viral load. Therefore, the
increased risk of disease progression among co-infected animals
could not be attributed, in this case, to an increase in SIV viral
load. This is in contrast to human studies describing transient
increases in HIV viral load during parasitemia [11,12]. The
decreased SIV load is probably the result of chloroquine treatment
which is known do decrease viral load in HIV infections [23]. Our
treatment of the Plasmodium-infected animals could have artificially
lowered SIV viral load, which will be investigated in future studies.
Modulation of CD4+ and CD8+ T cells occurs during P.
cynomolgi parasitemia, while co-infection accelerates
CD4+ T cell decline
CD4+ T cells are required for the development and
maintenance of a CD8+ T cell response [24,25] as well as the
optimal activation and development of the B cell antibody
response [26]. To model a proliferative immune response to
infection, four-color flow cytometry was utilized to follow changes
in B cells and T cell subsets over the course of the infections
(Table 1). In the figures displayed and in the statistical analysis
performed, data from animals in each cohort were grouped
through day 318 post P. cynomolgi infection. After day 318 the
animal numbers declined rapidly from AIDS progression. For
statistical analysis the malaria-only animals were compared to the
uninfected control animals, and the co-infected animals were
compared to the SIV-only animals following SIV infection
through day 318. Dynamics of lymphocyte changes for individual
animal are shown throughout the entire disease course in the
Supplementary Figures S1 and S2. A characteristic immune
response was observed among the malaria-only animals. CD4+
and CD8+ T cells (Figure 3A and B) increased in number in
response to parasitemias, with each population having a sustained
increase following the third parasitemia. CD4+/CD8+ T cell
ratios fluctuated with the initial parasitemias but stabilized
following the third (Figure 3C).
Following the fourth parasitemia, an adaptive immune response
against Plasmodium would have been well developed. We wanted to
address the question about SIV’s immunosuppressive effects on
the developed anti-malarial immune response and the effects of
parasite-specific immune activation on SIV progression. After the
third relapse, all SIV-infected animals were inoculated with SIV/
Delta/B670. The SIV-infected animals had characteristic periph-
eral CD4+ T cell depletion (Figure 3A), but this decline was more
than twice as rapid in the co-infected group than in the SIV-only
group (regression analysis: slope for SIV/malaria=23.30,
SIV-only=21.35; p=0.028). The CD4+ T cells of the co-
infected group increased in number in response to parasitemia
prior to SIV inoculation, responded slightly to the subsequent
parasitemia following SIV infection just before day 120, and failed
to respond to the following parasitemias. This would suggest a
Figure 2. Decreased survival among co-infected animals was
not associated with increased viral load. (A) Kaplan-Meier curve
showing survival in the co-infected group (solid line; 1657 group
survival days) and SIV-only group (dashed line; 2657 group survival
days). Individual rhesus plasma viral RNA levels are shown for (B) co-
infected and (C) SIV-only groups. Averaged viral set points (day 114)
were 2.57610
6 and 9.95610
6 RNA copies/ml plasma, respectively.
doi:10.1371/journal.pone.0007139.g002
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exposures, supporting what was observed as an increased risk of
infection and development of clinical malaria in human co-
infection studies [3–10]. All co-infected animals responded to
chloroquine treatment by clearing the parasite blood-stage
throughout the study (data not shown).
Following SIV infection the CD8+ T cells of the SIV-only group
significantly expanded over time (Figure 3B) when compared to the
control animals (regression analysis: SIV-only=2.01; uninfected
animals=0.09; p=0.003). The CD8+ T cells of the co-infected
animals initially declined (days 120–200, Figure 2B), but the
interaction over time was not significant when compared to the
SIV-only group. All SIV-infected animals had a decline in CD4+/
CD8+ T cell ratios (Figure 3C), but this decline was nearly twice as
rapid in the co-infected group than in the SIV-only group (regression
analysis: SIV/malaria=20.0029. SIV-only group=20.0016;
p=0.009). This more rapid decline in CD4+ Tc e l l sa n dC D 4 +/
CD8+ T cell ratios, both markers for HIV and SIV progression,
supports the more rapid SIV progression observed among the co-
infected animals.
Co-infection alters T-cell subset dynamics
To further characterize T cell subset dynamics during
both infections, naı ¨ve (CD95-CD28+), central memory (CD95+
CD28+), and activated memory (CD45RA2CCR5+) CD4+ T
cells were quantified by four-color flow cytometry. Naı ¨ve T cells
respond to pathogens that an individual’s immune system has not
yet encountered and replenishes lost memory CD4+ T cells, such
as those lost due to HIV infection. This decrease in naı ¨ve CD4+ T
cells has been associated, in non-rapid progressors, to SIV disease
progression [15]. The loss of activated (SIV-specific and parasite-
specific) memory CD4+ T cells by the SIV infection would
increase pressure on replenishing the lost memory CD4+ T cells,
increasing the naı ¨ve CD4+ T cell pool depletion and driving SIV
progression. The numbers of naı ¨ve CD4+ T cells fluctuated in
response to the parasite blood stage during relapses (malaria-only
group; Figure 4A). Following SIV infection naı ¨ve CD4+ T cells
were depleted more rapidly among the co-infected animals than
among the SIV-only animals [regression analysis; SIV-only
slope=21.23, SIV-malaria slope=22.77, p=0.048; (Figure 4A)].
Protective memory, such as antibody production and Th1/Th2
T cell and CD8+ T cell effector functions, are mediated by tissue-
homing effector memory T cells. Central memory (CM) T cells
migrate to secondary lymphoid organs in order to respond to
subsequent antigen exposure [27]. CM CD4+ T cells (Figure 4B)
and CCR5+ memory CD4+ T cells (Figure 5) proliferatively
responded to parasitemia, presumably developing the adaptive
immune response against the malaria parasite. Representative flow
cytometry results of an animal in each group (CCR5+ memory
CD4+ T cells) are shown in Figure 5A, and individual animals are
Figure 3. Impact of co-infection on CD4+ and CD8+ T cell
dynamics and CD4+/CD8+ T cell ratios. Four-color flow cytometry
showing T cell dynamics for (A) CD4+ T cells (CD3+CD202CD4+CD82),
(B) CD8+ T cells (CD3+CD202CD42CD8+), and (C) CD4+/CD8+ T cell
ratios. In this and subsequent figures, results from animals were
averaged through day 318. The downward arrow indicates time of SIV
inoculation (day 86). Parasitemias are indicated on the x-axis by a green
x (malaria-only) or an open purple triangle (SIV/malaria). SIV-only
animals were sampled starting at SIV infection, and the malaria-only
animals were sampled until the group stopped relapsing. Results for
individual animals throughout the course of infection are shown in
Figure S1.
doi:10.1371/journal.pone.0007139.g003
Table 1. Lymphocyte subsets based on cell surface markers
as determined by four-color flow cytometry.
Cell Marker
T cell subtype FITC PE APC PerCP
CD4+ T cells CD3+ CD202 CD4+ CD82
CD8+ T cells CD3+ CD202 CD42 CD8+
B cells CD32 CD20+
central memory CD4+ T cells CD95+ CD28+ CD3+ CD82
effector memory CD4+ T cells CD95+ CD282 CD3+ CD82
naı ¨ve CD4+ T cells CD952 CD29+ CD3+ CD82
CCR5+ memory CD4+ T cells CD45RA2 CCR5+ CD3+ CD82
doi:10.1371/journal.pone.0007139.t001
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following SIV infection among all SIV-infected animals
(Figure 4B), and the co-infected animals failed to generate a CM
CD4+ T cell response to parasitemias as observed among the
malaria-only animals except for the longest surviving co-infected
animal (DK36; Figure S2A). CCR5+ memory CD4+ T cells
dramatically responded to parasitemias among the co-infected
animals in a similar manner as the malaria-only animals
(Figure 5C). Following SIV infection, this population was rapidly
depleted and failed to respond to subsequent parasitemias.
Anti-Plasmodium and anti-SIV antibody responses are
altered in co-infected animals
B cells are an essential component of the adaptive immune
system that has the principal function of producing specific
antibodies against antigens of invading pathogens. Prior to SIV
infection, B cells of the animals in the co-infected group initially
responded to parasitemias in a similar manner as the malaria-only
group (Figure 6A). Following SIV infection there was a slight B cell
expansion, similar to the co-infected animals’ CD4+ T cell
response, following the subsequent parasitemia, but there was little
or no proliferative response to the following parasitemias
(Figure 6A). Except for the longest co-infected survivor, which
had a similar but delayed B cell proliferation response as the
malaria-only animals, all of the co-infected animals’ B cell counts
progressively declined to a significant level of depletion as the SIV
infection progressed (Figure S1).
To profile the B cell functional response against both SIV and
Plasmodium during co-infection,enzyme-linked immunosorbent assays
(ELISAs) were used to monitor changes in IgG levels against an SIV
viral lysate and the parasite protein MSP1-19, a highly antigenic
blood-stage protein. The serum IgG response to the recombinant
malaria parasite MSP1-19 protein by ELISA increased following
sporozoite inoculation but decreased following SIV infection,
continuing to fluctuate but not reaching the same magnitude as
among the animals of the malaria-only group (Figure 6B). At the time
of SIV infection, though, the B cell count was much greater among
the malaria-only animals than among the co-infected animals, and
this could have impacted the magnitude of the anti-parasite IgG
response. The serum IgG response to the SIVmac viral lysate
antigens increased more rapidly (peaked at day 28–56 post SIV
inoculation) in the co-infected group than in the SIV-only group, as
measured by absorbance (Figure 6C) and by endpoint titer (data not
shown), and then declined. The IgG response among the SIV-only
animals gradually increased to a plateau. The two rapid progressors,
one in each of the SIV-infected groups, failed to generate an anti-
SIVmac IgG response that was significantly different than that of the
uninfected control animals (Figure 6C).
Discussion
The results of this study show that the most widely used non-
human primate models for HIV [14,28–36] and Plasmodium vivax
[21,37–40] infections in humans can be successfully combined.
Several consequences of P. cynomolgi and SIV co-infection of rhesus
macaques were observed, including an increased risk of SIV
disease progression and accelerated CD4 T-cell decline. Modula-
tion of CD4+ and CD8+ T cells occurs during P. cynomolgi
parasitemia, and co-infection alters these T-cell subset dynamics.
Anti-Plasmodium and anti-SIV antibody responses were also altered
in co-infected animals. These findings support previous reports of
deleterious consequences of HIV/Plasmodium co-infections in
humans [3–13] and establish an animal model system to further
study the immunological and biological consequences of co-
infection with these important pathogens.
Recent studies have found that, among conventional SIV
progressors, the naı ¨ve CD4+ T cell pool is progressively depleted,
most likely due to constant turnover of memory CD4+ T cells [15].
This suggests that there is replenishment of the memory CD4+ T
cell pool by the naı ¨ve T cell pool, eventually leading to depletion of
the naı ¨ve T cell pool and immune system collapse. A similar trend
is observed in the co-infected animals in the present study in which
there is a more rapid decline in the naı ¨ve CD4+ T cell pool. The
generation of CCR5+ memory and central memory CD4+ T cells
in response to the malaria parasite would be opportune targets for
SIV infection [41]. Activation of parasite-specific CD4+ T cells,
especially the CCR5+ CD4+ T cells, in response to parasitemia
could be driving the higher viral loads as has been observed in
HIV/Plasmodium co-infections [11,12]. We did not observe an
increased SIV load in co-infected animals; however, it is likely that
this result was affected by the treatment of parasitic animals with
chloroquine. Valuable information on the influences of co-
infection on viral load could be gained in future studies by
limiting chloroquine treatment following SIV infection while
closely monitoring parasite levels in co-infected animals. Addi-
tionally, it is possible that species-specific factors could be what is
driving the higher viral loads observed in co-infected humans.
Figure 4. CD4+ T cell subset dynamics in SIV-infected, P.
cynomolgi-infected and co-infected rhesus macaques. Four-color
flow cytometry was used to follow group changes in CD4+ T cell
subtypes (CD3+CD82) over the course of infections for (A) naı ¨ve
(CD952CD28+) and (B) central memory (CD95+CD28+) CD4+ cells.
Results for individual animals are shown in Figure S2.
doi:10.1371/journal.pone.0007139.g004
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PLoS ONE | www.plosone.org 5 September 2009 | Volume 4 | Issue 9 | e7139Figure 5. Plasmodium infection increases CCR5+ memory CD4+ T cell populations, which SIV infection rapidly eliminates. Four color
flow cytometry was used to determine the CCR5+ memory CD4+ T cell populations (CD3+CD82CD45RA2). (A) Representative results are shown for
animals DD82 (SIV/malaria), DJ80 (SIV-only), and DD39 (malaria-only). (B) Averaged results are depicted with individuals in each group including the
grouped uninfected animal.
doi:10.1371/journal.pone.0007139.g005
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generated in rhesus macaques infected with the parasite alone, and
the numbers of circulating CD4+ and CD8+ T cells increased in
response to parasitemia. Of the CD4+ T cell subtypes examined,
activated CCR5+ memory CD4+ T cells strongly proliferated in
response to parasitemia as well as central memory CD4+ T cells
which are generated to respond to subsequent infections. B cells
also proliferated in response to parasitemia, and a strong IgG
response to one of the immunodominant surface proteins (MSP1-
19) was observed. In the immediate period following co-infection
with SIV, there was a slight proliferative response by CD4+ T cells
and memory CCR5+ CD4+ T cells to the following parasitemia.
However, subsequently there was either a failure of the
proliferative response or rapid depletion of CD4+ T cells
responding to parasitemia.
The proliferative B cell responses and the associated anti-
parasite IgG response among the co-infected animals failed to
reach the same magnitude as the animals infected with the parasite
alone. While there is a difference in the numbers of B cells at the
time of the SIV infection, which could have an impact on the
magnitude of the anti-parasite B cell antibody response, the B cells
among the co-infected animals fail to generate a significant
proliferative response to parasitemias following SIV infection. This
declining B cell population and the lack of a proliferative B cell
response to parasitemia could possibly be due to inadequate CD4+
T cell help, either by central memory or newly activated parasite-
specific naı ¨ve CD4+ T cells. This altered antibody response could
have an impact on the parasite infection as a successful antibody
response is required for parasite clearance [20,42,43]. In contrast,
an anti-SIV antibody response was generated more rapidly in the
co-infected animals and then declined. While in animals infected
with SIV alone, the anti-SIV antibody response gradually
increased and plateaus. It is possible that immune activation from
the parasite infection primed the immune response to SIV.
Additional analysis of CD4+ T cell subsets as well as CD8+ T cell
subsets in the rhesus co-infection model could further define the
loss of parasite-specific and SIV-specific effector functions.
Future studies with larger numbers of animals will be necessary
to further characterize the SIV/malaria parasite co-infection
model piloted here. More frequent immunophenotyping of
lymphocytes during the co-infection will be needed to better
profile proliferation changes in response to parasitemia. Quanti-
fying changes in antigen-specific responses among CD4+ and
CD8+ T cells longitudinally will help to determine if the SIV
infection does indeed result in a loss of antigen recall to the malaria
parasite. This potential loss of antigen recall could lower the
threshold for developing clinical malaria when an HIV-infected
individual or a pregnant woman is repeatedly infected with
Plasmodium. Additionally, the immune activation associated with
Plasmodium infection could lower the threshold for HIV infection.
As we have demonstrated here, there is an increase in the numbers
of HIV-receptive CCR5+ CD4+ T cells in response to
parasitemia. Proinflammatory cytokines such as TNF-a, IL-1,
and IL-6, which are upregulated during malaria, increase HIV
proviral expression through the provirus modulatory enhancer
region (reviewed in [41]). Such chronic inflammation associated
with repeated Plasmodia and other infections could enhance HIV
progression and spread. This co-infection model would be ideal for
evaluating these situations.
Several combinations of SIV strains and Plasmodia species will
eventually need to be examined to model various aspects of HIV-1
and Plasmodium co-infection. The fulminant disease induced by P.
knowlesi in rhesus macaques more closely resembles severe P.
falciparum malaria than malaria generally induced by P. cynomolgi or
P. vivax. The form of malaria associated with the highest mortality
is P. falciparum induced cerebral malaria. There are data to suggest
that infections by certain simian Plasmodia species (e.g. P. knowlesi,
P. coatneyi,o rP. fragile in the rhesus macaque or other primates) can
mimic some aspects of the pathobiology of human cerebral
malaria [44–47]. The population that experiences cerebral
malaria is comprised mostly of children below 6 years of age.
Children are usually only infected with HIV congenitally or
Figure 6. B cell response and altered IgG responses to
Plasmodium and SIV among co-infected animals. (A) Peripheral
B cells (CD32CD20+) were followed by two-color flow cytometry.
Serum was used to determine the (B) anti-MSP1-19 IgG host response
and (C) anti-SIVmac lysate IgG response. Results using samples from
individual animals are shown in panels (B) and (C), and individual B cell
dynamics are shown throughout the course of infection in Figure S1.
doi:10.1371/journal.pone.0007139.g006
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Plasmodium co-infection in adults in which exposure to the parasite
usually occurs prior to infection with the lentivirus. Our group
does have experience with the P. coatneyi/rhesus macaque model of
malaria in pregnancy [48,49], and has also studied congenitally
acquired SIV infections [30,36]. Therefore, we are well-positioned
to adapt these models in future studies to address specific questions
related to the impact of co-infection during pregnancy.
Materials and Methods
Ethics Statement
All animals were housed and handled at the Tulane National
Primate Research Center (TNPRC) in strict accordance with the
Guide for Care and Use of Laboratory Animals, and all animal
protocols were approved by TNPRC Institutional Animal Care
and Use Committee. TNPRC also adheres to the principles of
humane animal experimentation proposed in The Principles of
Humane Experimental Technique (1959). All parasite-infected animals
were monitored without anesthesia for parasitemia, and the blood-
stage infection was treated with chloroquine. All SIV infected
animals were under close veterinary observation and, following the
progression to AIDS, were humanely euthanized.
Animals
Ten Indian rhesus macaques were inoculated intravenously
with either 4,000 (malaria-only) or 12,000 (SIV/malaria) sporo-
zoites. Following the third parasite relapse, ten animals (SIV/
malaria and SIV-only) were inoculated intravenously with SIV/
Delta/B670. All parasite-infected animals were monitored daily
without anesthesia for parasitemia, and the blood-stage infection
was treated with chloroquine (7 mg/kg/day for five days).
SIV and virus quantification
The SIV/Delta/B670, a highly pathogenic virus, has been
developed and used at the TNPRC [18], and had been previously
prepared in primary rhesus peripheral blood mononuclear cells.
Following the third parasite relapse, ten animals (SIV/malaria and
SIV-only) were inoculated intravenously with SIV/Delta/B670.
Viral load was determined by branched-DNA analysis using
EDTA plasma (Bayer Diagnostics, Inc.).
Sporozoite preparation and infection
A splenectomized, adult rhesus macaque was inoculated in the
saphenous vein with approximately 10
6 previously frozen
parasitized red blood cells to initiate a blood stage infection.
When gametocytes first appeared in the blood, Anopheles stephensi
mosquitoes from the mosquito colony at TNPRC were fed
(300 per day) on the anesthetized donor animal. Following this
cycle the donor animal was treated with a curative dose of
chloroquine (7 mg/kg/day) for five days. Infected mosquitoes
were maintained at 27uC for two weeks, and sporozoites were
dissected from the salivary glands for the experimental animal
inoculation. Ten animals were inoculated intravenously with
either 4,000 (malaria-only) or 12,000 (SIV/malaria) sporozoites;
the difference in sporozoite numbers was a result of decreased
sporozoite recovery for the malaria-only inoculum preparation.
Additionally, all parasite-infected animals were treated with
chloroquine when parasites appeared in the blood, minimizing
possible impact of the differences in sporozoite number.
Sample collection
Heparin and EDTA treated blood were collected 1) every 7
days for 28 days following SIV inoculation and every 30 days
thereafter for the SIV-infected groups; or 2) every 7 days following
sporozoite inoculation for 28 days and every 14 days thereafter.
Lymphocyte immunophenotypic analysis
Peripheral lymphocyte counts were determined by an automat-
ed, complete blood count. Lymphocyte subset changes were
followed by four-color flow cytometry. Briefly, 100 ml of EDTA
treated whole blood was stained with CD3-APC, CD8-PerCP, and
(i) CD45RA-FITC and CCR5-PE, (ii) CD95-FITC and CD28-PE,
or CD4-APC, CD8-PerCP, CD3-FITC, and CD20-PE. All
antibodies were obtained from BD Biosciences. Following whole
blood lysis, stained lymphocytes were fixed in 1% paraformalde-
hyde, acquired on a FACSCalibur (BD Biosciences), and analyzed
using CellQuest (BD Biosciences).
Statistical analysis
Regression analyses were used to test the null hypotheses that 1)
malaria parasite infection has no impact on the change of outcome
compared to the uninfected control animals (from day 0), 2) SIV
alone has no impact on the change in outcome between the
control animals and SIV-only animals (from the SIV inoculation
date of day 86 to day 318), and 3) malaria plus SIV has no impact
on change in outcome between SIV-only and SIV/malaria
animals (from day 86). These analyses take into account initial
differences in analyzed values among animals while examining
rates of change. A linear relationship between time and outcome
was assumed, and generalized estimating equations were used to
estimate the parameters and their standard errors.
Immunoassays
Rhesus IgG responses to a recombinant P. vivax malaria parasite
protein MSP1-19 [yP.v.200 MSP1-19 2905/6 (MRA-47, MR4,
ATCC Manassas Virginia)] [50] were determined by enzyme-
linked immunosorbent assay (ELISA). 96-well ELISA plates [low
volume, high binding ELISA plates (Corning, Inc.)] were coated
with 10 ng/well of recombinant protein in coating buffer (0.1 M
sodium bicarbonate, pH 9.2) overnight at 4uC. Plates were washed
with wash buffer [PBS with 0.5% Tween 20 (Sigma-Aldrich)],
blocked for one hour with StartingBlock T20 PBS (Pierce
Biotechnology), dried, and stored at 4uC until use. Sera were
serially diluted, starting with a 1:10 dilution, with carrier buffer
(PBS supplemented with 10% StartingBlock T20 PBS), and 50 ml
of diluted serum, in duplicate, was added to the 96-well plates and
incubated at room temperature for one hour. Plates were washed
(56150 ml wash buffer), incubated with a biotinylated mouse anti-
human IgG antibody [(BD Pharmingen); 1:1000 dilution in carrier
buffer], washed, and incubated for one hour at room temperature
with an avidin-horseradish peroxidase antibody [(BD Pharmin-
gen); 1:1000 dilution in carrier buffer]. Plates were washed and
incubated for 30 minutes with 50 ml substrate [1-step Turbo
TMB-ELISA (Pierce Biotechnology)]. Reactions were stopped
with 50 ml 1 M phosphoric acid and absorbance read at A450.
Rhesus IgG responses to SIV [SIVmac251 purified viral lysate
(ZeptoMetrix, New York)] were determined by ELISA. 96-well
plates were coated with 34.29 ng/well of SIV lysate for one hour
at 37uC. Following a wash (16200 ul wash buffer), plates were
blocked for one hour with 4% milk [PBS with Blocking-grade
blocker (Bio-Rad)], washed, and incubated overnight at 4uC with
serum serially diluted 1:4 starting at 1:400 in PBS. Plates were
washed and incubated with 50 ml of an anti-human IgG-
horseradish peroxidase antibody [(BD Pharmingen); 1:2000
dilution in wash buffer] for two hours at room temperature.
Plates were washed (56200 ml), incubated for 20 minutes with
50 ml substrate [1-step Turbo TMB-ELISA (Pierce Biotechnolo-
Coincident AIDS and Malaria
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and the absorbance was read at A450.
Supporting Information
Figure S1 Individual animal responses to SIV and/or malaria
parasite infection by group for peripheral lymphocytes. Flow
cytometry was used to follow changes in peripheral CD4+ (CD20-
CD3+CD4+) T cells (A), CD8+ (CD20-CD3+CD8+) T cells (B),
and B (CD20+CD3-) cells (C). The malaria-only animals were
followed until they stopped relapsing and are shown out to day 180
while the SIV-infected animals are shown out to day 630.
Parasitemias are shown on the x-axis as an open triangle (SIV/
malaria) or a green x (malaria-only), and SIV infection (day 86) is
indicated with an arrow. The grouped control animal is shown
with the purple dashed line.
Found at: doi:10.1371/journal.pone.0007139.s001 (1.26 MB
DOC)
Figure S2 Individual animal responses by group of naı ¨ve and
central memory CD4+ T cells. Central memory (CD95+CD28+)
CD4+ T cell (A) and naı ¨ve (CD95-CD28+) CD4+ T cell (B)
dynamics in response to SIV and/or malaria parasite infection.
The malaria-only animals were followed until they stopped
relapsing and are shown out to day 180 while the SIV-infected
animals are shown out to day 630. Parasitemias are shown on the
x-axis as an open triangle (SIV/malaria) or a green x (malaria-
only), and SIV infection (day 86) is indicated with an arrow. The
grouped control animal is shown with the purple dashed line.
Found at: doi:10.1371/journal.pone.0007139.s002 (0.85 MB
DOC)
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